Pipeline

Clinical Trials in Multiple Solid Tumor Indications

The Lumicellâ„¢ Direct Visualization System (DVS)* has potential utility in multiple solid tumor indications. Over 800 patients have been clinically evaluated in seven different cancer types in 18 leading medical centers across the United States.

 

(We recommend viewing this pipeline image in landscape view on mobile devices) | View full-size image

 

 

*CAUTION: LUMISIGHT and Lumicell Direct Visualization System (DVS) are investigational products that are limited by Federal (or United States) law to investigational use. LUMISIGHT and Lumicell DVS are not authorized for marketing for any indication in any jurisdiction.